We are live on ! Find out more
EIM

Essex Investment Management Portfolio holdings

AUM $632M
1-Year Est. Return 95.36%
This Fund
S&P 500
This Quarter Est. Return
+3.93%
1 Year Est. Return
+95.36%
3 Year Est. Return
+271.62%
5 Year Est. Return
+354.98%
10 Year Est. Return
+3,586.14%
AUM
$607M
AUM Growth
-$13.7M
Cap. Flow
-$17.5M
Cap. Flow %
-2.88%
Top 10 Hldgs %
21.7%
Holding
410
New
79
Increased
109
Reduced
121
Closed
71

Top Sells

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$8.31M
2
META icon
Meta Platforms (Facebook)
META
+$7.78M
3
GPRO icon
GoPro
GPRO
+$7.18M
4
LLY icon
Eli Lilly
LLY
+$7.05M
5
AGN
Allergan plc
AGN
+$5.59M

Sector Composition

Rank Sector Weight
1 Technology 26.07%
2 Healthcare 14.08%
3 Industrials 10.62%
4 Energy 10.51%
5 Consumer Discretionary 10.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
76
Procter & Gamble
PG
$335B
$2.11M 0.35%
25,124
-38
-0.2% -$3.24K
PNRA
77
DELISTED
Panera Bread Co
PNRA
$2.11M 0.35%
10,268
-365
-3% -$74K
BWA icon
78
BorgWarner
BWA
$14B
$2.09M 0.34%
60,121
+28,978
+93% +$935K
ZLTQ
79
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$2.07M 0.34%
47,588
+19,719
+71% +$795K
CAVM
80
DELISTED
Cavium, Inc.
CAVM
$2.06M 0.34%
+32,983
New +$1.9M
RAVN
81
DELISTED
Raven Industries Inc
RAVN
$2.05M 0.34%
81,435
+38,046
+88% +$904K
CL icon
82
Colgate-Palmolive
CL
$73.6B
$1.98M 0.33%
30,262
-48
-0.2% -$3.29K
REGN icon
83
Regeneron Pharmaceuticals
REGN
$82.2B
$1.97M 0.32%
5,375
AJG icon
84
Arthur J. Gallagher & Co
AJG
$65.5B
$1.96M 0.32%
37,776
-1,905
-5% -$95.8K
FIVE icon
85
Five Below
FIVE
$13.2B
$1.9M 0.31%
47,500
-717
-1% -$28.2K
CUTR
86
DELISTED
Cutera, Inc.
CUTR
$1.89M 0.31%
109,175
+44,122
+68% +$660K
RVNC
87
DELISTED
Revance Therapeutics, Inc.
RVNC
$1.89M 0.31%
91,228
+5,228
+6% +$87.5K
SINA
88
DELISTED
Sina Corp
SINA
$1.87M 0.31%
30,822
EBIX
89
DELISTED
Ebix Inc
EBIX
$1.85M 0.3%
32,400
LITE icon
90
Lumentum
LITE
$82.6B
$1.82M 0.3%
47,128
-653
-1% -$26K
VCRA
91
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$1.82M 0.3%
98,326
+6,871
+8% +$123K
IPGP icon
92
IPG Photonics
IPGP
$3.71B
$1.81M 0.3%
18,356
-51
-0.3% -$4.76K
CYNO
93
DELISTED
Cynosure, Inc. Class A
CYNO
$1.8M 0.3%
+39,546
New +$1.81M
RSPP
94
DELISTED
RSP Permian, Inc.
RSPP
$1.8M 0.3%
+40,251
New +$1.67M
PATK icon
95
Patrick Industries
PATK
$2.79B
$1.79M 0.29%
52,668
-1,530
-3% -$45.1K
BIDU icon
96
Baidu
BIDU
$35.6B
$1.76M 0.29%
+10,700
New +$1.82M
NXTM
97
DELISTED
NxStage Medical Inc.
NXTM
$1.74M 0.29%
66,511
-20,216
-23% -$500K
PGEM
98
DELISTED
Ply Gem Holdings, Inc.
PGEM
$1.74M 0.29%
106,927
CORT icon
99
Corcept Therapeutics
CORT
$12.1B
$1.69M 0.28%
232,267
+59,878
+35% +$469K
SNA icon
100
Snap-on
SNA
$21.1B
$1.66M 0.27%
9,664
-28
-0.3% -$4.55K

Similar funds

Essex Investment Management's Q4 2016 Portfolio in Review

As of Q4 2016, Essex Investment Management held 410 positions worth $607M, down 2.2% from $621M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Essex Investment Management's Q4 2016 filing shows 79 new, 109 increased, 121 reduced and 71 closed positions. Its largest new stake was APA Corp: 89,478 shares worth $5.68M. The largest sale was S&P Global, an estimated $8.31M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.

  • Essex Investment Management's largest Q4 2016 buy was APA Corp: 89,478 shares worth $5.68M.
  • Essex Investment Management added most to Southwestern Energy Company in Q4 2016, an estimated $6.22M increase.
  • Essex Investment Management's biggest Q4 2016 reduction was Meta Platforms (Facebook), cutting an estimated $7.78M.
  • Essex Investment Management fully exited S&P Global in Q4 2016, selling an estimated $8.31M.
  • Essex Investment Management's ten largest holdings make up 22% of its $607M portfolio in Q4 2016.
  • Essex Investment Management opened 79 new positions and closed 71 in Q4 2016.
  • Essex Investment Management's portfolio value fell 2.2% quarter-over-quarter to $607M.

Based on Essex Investment Management's 13F filing for Q4 2016, filed 8 Feb 2017.